TipRanks
Chicago Atlantic BDC (LIEN)
NASDAQ:LIEN
US Market
Want to see LIEN full AI Analyst Report?
EarningsQ1 2026 Earnings Report

Chicago Atlantic BDC (LIEN) Q1 2026 Earnings Report

53 Followers

LIEN Q1 2026 EPS Results

Actual EPS$0.44
Consensus EPS$0.35
Beat/MissBeat by +$0.09
One Year Ago EPS$0.33

LIEN Q1 2026 Revenue Results

Actual Revenue$16.70M
Expected Revenue$14.31M
Beat/MissBeat by +$2.39M
YoY Revenue Growth+40.09%

Earnings Announcement Details

QuarterQ1 2026
Date05/14/2026
TimeBefore Open
Conference CallThursday, May 14, 2026
LIEN Upcoming Earnings
Chicago Atlantic BDC's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

Q1 2026 Earnings Call Audio

LIEN Q1 2026 Earnings Call
0:00 / 0:00

Q1 2026 Earnings Slide Deck

Q1 2026 Earnings Call Summary

Q1 2026
Earnings Call Date:May 14, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call emphasized record financial performance, strong portfolio yields, conservative leverage, and meaningful origination momentum—particularly notable given regulatory tailwinds for the cannabis market. Key positives include record NII and funding activity, high senior-secured yields, zero nonaccruals, and a large $810M pipeline. Offsetting items include a $1.4M net unrealized loss from spread widening, higher interest expense and operating costs, modest cash on hand, and some execution uncertainty around accessing additional capital under the shelf. On balance, the highlights are more numerous and material than the lowlights, indicating solid operational execution and a favorable positioning to benefit from improving industry dynamics.
Company Guidance
The company guided to a disciplined, low‑leverage growth plan—maintaining its $0.34 quarterly dividend, staying well below the BDC average 1.3x debt/equity (currently 0.18x with $54.5M drawn), and aiming to opportunistically use available financing (May 13 liquidity ~$51.5M: $50M revolver capacity + $1.5M cash; shelf registration for up to $500M) and, possibly, full revolver utilization by year‑end—while preserving strict underwriting. Key portfolio metrics underpinning that guidance include a gross weighted average debt yield of ~15.8% (vs. 10.8% public BDC avg), 100% of debt senior secured, ~94% fixed‑rate or floored, only 1.3% exposure to sub‑debt/equity (vs. 25.5% peer avg), no nonaccruals (industry avg 3.4%), and minimal software exposure (2.6%). Recent activity and expectations driving growth: Q1 funded $93.9M across 7 companies (3 new), net investment income of $10.0M or $0.44/share, net deployments $32M, $63.4M in repayments/refis (including a $38.3M refinancing), $13.7M unfunded commitments, and an $810M origination pipeline (≈$482M cannabis, $328M non‑cannabis). They also noted limited rate sensitivity (a 100 bp benchmark drop would cut interest income by <15 bps) and expect regulatory tailwinds and increased M&A to lift originations, but will remain conservative and focused on downside protection.
Record Net Investment Income and EPS
Net investment income reached a record $10.0 million, or $0.44 per share, up from $8.3 million or $0.36 per share in Q4 2025 (NII increase ~20.5%; EPS increase ~22.2%).
Record Quarterly Originations and Portfolio Growth
Funded a record $93.9 million across 7 portfolio companies (including 3 new borrowers), growing the portfolio to the largest level in company history; net investment activity for the quarter was $32.0 million.
High Yielding, Senior-Secured Debt Portfolio
Gross weighted average yield on debt investments was ~15.8% (in line with prior quarter) versus 10.8% for the average public BDC (≈+5.0 percentage points). 100% of the debt portfolio is senior secured and only 1.3% of total investments have exposure to sub-debt/equity/JV structures (vs. public BDC average 25.5%).
Strong Interest Rate Protection and Low Credit Stress
Approximately 94% of the portfolio at par is fixed rate or floored, limiting downside from rate declines (a 100 bp drop in benchmark rates estimated to reduce annualized interest income by <15 bps). The company reported zero nonaccruals (industry average 3.4%).
Conservative Leverage Position
Company is underlevered with $54.5 million of debt outstanding and a 0.18x debt-to-equity ratio versus a BDC industry average of 1.3x, providing capacity to expand liquidity and deploy additional leverage opportunistically.
Dividend Stability
Declared a $0.34 dividend for the quarter, marking the seventh consecutive quarter at that rate, supported by the company's record NII and underwriting discipline.
Improved Size of Investable Pipeline and Liquidity Actions
Pipeline of potential debt transactions totaled approximately $810 million (≈$482M cannabis, $328M non-cannabis). As of May 13, 2026 the company reported ~$51.5 million of liquidity (≈$50M undrawn borrowing capacity subject to availability plus ~$1.5M cash) and has filed a shelf registration to issue up to $500 million in securities to expand optionality.
QoQ Revenue Growth
Gross investment income increased to $16.7 million from $14.2 million in Q4 2025, a rise of $2.5 million (~17.6%), driven primarily by higher interest income from new originations.

LIEN Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Nov 05, 2026
2026 (Q3)
0.38 / -
0.42―
2026 (Q2)
0.40 / 0.34
0.340.00% (0.00)
2026 (Q1)
0.35 / 0.44
0.3333.33% (+0.11)
2025 (Q4)
0.37 / 0.36
0.352.86% (+0.01)
2025 (Q3)
0.34 / 0.42
0―
2025 (Q2)
0.36 / 0.34
0.2161.90% (+0.13)
2025 (Q1)
- / 0.34
0.08325.00% (+0.26)
2024 (Q4)
0.34 / 0.33
0.08312.50% (+0.25)
2024 (Q3)
-0.01 / 0.00
0.26―
2024 (Q2)
0.07 / 0.21
0.31-32.26% (-0.10)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed